ATE279113T1 - Hypoxanthin- und thiohypxanthin-verbindungen - Google Patents

Hypoxanthin- und thiohypxanthin-verbindungen

Info

Publication number
ATE279113T1
ATE279113T1 AT00953925T AT00953925T ATE279113T1 AT E279113 T1 ATE279113 T1 AT E279113T1 AT 00953925 T AT00953925 T AT 00953925T AT 00953925 T AT00953925 T AT 00953925T AT E279113 T1 ATE279113 T1 AT E279113T1
Authority
AT
Austria
Prior art keywords
compounds
thiohypxanthine
hypoxanthine
inhibitors
formula
Prior art date
Application number
AT00953925T
Other languages
English (en)
Inventor
Mark Chasin
Peter Hofer
David Cavalla
Original Assignee
Euro Celtique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa
Application granted granted Critical
Publication of ATE279113T1 publication Critical patent/ATE279113T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/36—Sulfur atom
    • C07D473/38—Sulfur atom attached in position 6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/28—Oxygen atom
    • C07D473/30—Oxygen atom attached in position 6, e.g. hypoxanthine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AT00953925T 1999-08-12 2000-08-09 Hypoxanthin- und thiohypxanthin-verbindungen ATE279113T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14862399P 1999-08-12 1999-08-12
PCT/US2000/021836 WO2001011967A1 (en) 1999-08-12 2000-08-09 Novel hypoxanthine and thiohypoxanthine compounds

Publications (1)

Publication Number Publication Date
ATE279113T1 true ATE279113T1 (de) 2004-10-15

Family

ID=22526585

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00953925T ATE279113T1 (de) 1999-08-12 2000-08-09 Hypoxanthin- und thiohypxanthin-verbindungen

Country Status (7)

Country Link
EP (1) EP1202628B1 (de)
JP (1) JP2003506467A (de)
AT (1) ATE279113T1 (de)
AU (1) AU6629000A (de)
CA (1) CA2379356A1 (de)
DE (1) DE60014915T2 (de)
WO (1) WO2001011967A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060052404A1 (en) * 2001-10-26 2006-03-09 Rudolph Alfred R Pharmaceutical formulations comprising substituted xanthine compounds
AR039385A1 (es) 2002-04-19 2005-02-16 Astrazeneca Ab Derivados de tioxantina como inhibidores de la mieloperoxidasa
CN114588161A (zh) * 2020-12-07 2022-06-07 四川大学华西医院 具有防治肺炎作用的次黄碱衍生物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL24642A (en) * 1965-11-18 1971-06-23 Rashi M Method for preparation of 6-thioxo purines from 6-methylthio purines
GB9312853D0 (en) * 1993-06-22 1993-08-04 Euro Celtique Sa Chemical compounds
DE69531506T2 (de) * 1994-12-13 2004-06-24 Euroceltique S.A. Arylthioxanthine
US5864037A (en) * 1996-06-06 1999-01-26 Euro-Celtique, S.A. Methods for the synthesis of chemical compounds having PDE-IV inhibitory activity
CN1294590A (zh) * 1997-12-12 2001-05-09 欧罗赛铁克股份有限公司 通过2－硫代黄嘌呤制备3－取代腺嘌呤的方法

Also Published As

Publication number Publication date
EP1202628A4 (de) 2002-10-30
DE60014915D1 (de) 2004-11-18
EP1202628A1 (de) 2002-05-08
CA2379356A1 (en) 2001-02-22
DE60014915T2 (de) 2005-10-13
EP1202628B1 (de) 2004-10-13
JP2003506467A (ja) 2003-02-18
WO2001011967A1 (en) 2001-02-22
AU6629000A (en) 2001-03-13

Similar Documents

Publication Publication Date Title
TR200002480T2 (tr) İzaşemi tedavisi için guanidin türevleri
DK1070056T3 (da) Phthalazinon-PDE III/IV-inhibitorer
DK1200412T3 (da) Antiproliferative imidazolforbindelser
TR200201505T2 (tr) Terapötik maddeler olarak pirazolopirimidinler
PT1268471E (pt) Derivados n-heterociclicos como inibidores de nos
IL156873A0 (en) Pharmaceutically active piperidine derivatives
ATE302775T1 (de) Carbolinderivate
PT1206467E (pt) Derivados n-heterociclicos como inibidores de nos
ATE301653T1 (de) Pyrazolopyridine
ATE300541T1 (de) Pyrazolopyridinderivate
ATE346067T1 (de) Carbolinderivate
GB0308201D0 (en) Novel compounds
DE60112306D1 (de) Kondensierte pyrazindionderivate als pde5 inhibitore
PE20030061A1 (es) 1-biaril-1,8-naftiridin-4-ona como inhibidores de fosfodiesterasa-4
MXPA04006041A (es) Antivirales de piridoquinoxalina.
AU2001263278A1 (en) Cyclic gmp-specific phosphodiesterase inhibitors
TR200201128T2 (tr) PDE4 inhibitörleri olarak tetrahidrotiyopiranfitalazinon türevleri.
PT1109560E (pt) Compostos uteis como inidores de aicarft
NO20015892D0 (no) Inhibitorer av metallproteinaser
AU2001296699A1 (en) Condensed pyrazindione derivatives as pde inhibitors
DK1015437T3 (da) Benzoxazin- og benzothiazin-derivater og deres anvendelse i lægemidler
DE60213798D1 (de) Carbolinderivate als pdev inhibitoren
ATE279113T1 (de) Hypoxanthin- und thiohypxanthin-verbindungen
SE9904128D0 (sv) Novel compounds
ATE246174T1 (de) Tosylprolin-derivate als thymidylat-synthase inhibitoren

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties